Research location
Kingston
Pennsylvania, United States
Advertisement
Research activity in Kingston
Pennsylvania, United StatesCureCurrent currently publishes aggregate city-level research activity for this location: 50 trials and 50 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Kingston
50 linked trials · page 1 of 1Clarifying the Optimal Application of SLT Therapy TrialNCT04967989 · 2021-09-07 · 1 site observation
RECRUITING
Nesvategrast (OTT166) in Diabetic Retinopathy (DR)NCT05409235 · 2022-07-29 · 1 site observation
COMPLETED
A Study to Evaluate THR-687 Treatment for Diabetic Macular Oedema.NCT05063734 · 2021-08-27 · 1 site observation
TERMINATED
MRCT Evaluating NCX 470 vs. Latanoprost in Subjects With Open-Angle Glaucoma or Ocular HypertensionNCT04630808 · 2020-11-09 · 1 site observation
COMPLETED
Study of a High-Dose Aflibercept in Participants With Diabetic Eye DiseaseNCT04429503 · 2020-06-29 · 1 site observation
COMPLETED
Study to Assess the Efficacy, Safety and Tolerability of AKB-9778 Ophthalmic Solution as and Adjunct to Latanoprost in Patients With Ocular Hypertension or Open Angle GlaucomaNCT04405245 · 2020-06-06 · 1 site observation
COMPLETED
Efficacy and Safety of Brolucizumab vs Aflibercept in Patients With Visual Impairment Due to Diabetic Macular EdemaNCT03917472 · 2019-07-17 · 1 site observation
COMPLETED
Study of Efficacy and Safety of Brolucizumab vs. Aflibercept in Patients With Visual Impairment Due to Diabetic Macular EdemaNCT03481634 · 2018-07-23 · 1 site observation
COMPLETED
A Study to Assess Long-Term Safety of the CyPass Micro-Stent in Patients Completing the COMPASS TrialNCT02700984 · 2016-03-30 · 1 site observation
COMPLETED
Comparison of Bimatoprost Sustained Release (SR) to Selective Laser Trabeculoplasty (SLT) in Adults With Open-Angle Glaucoma or Ocular HypertensionNCT02507687 · 2015-08-27 · 1 site observation
COMPLETED
Multicenter Post-Approval Study Of The Glaukos® iStent® Trabecular Micro-Bypass Stent System In Conjunction With Cataract SurgeryNCT01841450 · 2013-07-01 · 1 site observation
UNKNOWN
Study of Palifosfamide-tris in Combination With Carboplatin and Etoposide in Chemotherapy Naïve Patients With Extensive-Stage Small Cell Lung Cancer (The MATISSE Study)NCT01555710 · 2012-06-08 · 1 site observation
TERMINATED
Docetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast CancerNCT01547741 · 2012-04-01 · 1 site observation
COMPLETED
The BEACON Study (Breast Cancer Outcomes With NKTR-102)NCT01492101 · 2011-12-01 · 1 site observation
COMPLETED
Study of Intravitreal Aflibercept Injection (IAI; EYLEA®; BAY86-5321) in Patients With Diabetic Macular EdemaNCT01363440 · 2011-05-01 · 1 site observation
COMPLETED
Eribulin With Trastuzumab as First-line Therapy for Locally Recurrent or Metastatic HER2 Positive Breast CancerNCT01269346 · 2010-12-01 · 1 site observation
COMPLETED
A Study of Chemotherapy and Ramucirumab Versus Chemotherapy Alone in Second Line Non-Small Cell Lung Cancer (NSCLC) Participants Who Received Prior First Line Platinum-based ChemotherapyNCT01168973 · 2010-12-01 · 1 site observation
COMPLETED
Ranibizumab for Edema of the Macula in Diabetes: Protocol 3 With High Dose - the READ 3 StudyNCT01077401 · 2010-02-01 · 1 site observation
COMPLETED
Ixabepilone + Carboplatin Metastatic Breast CancerNCT01075100 · 2010-01-01 · 1 site observation
COMPLETED
A Study of REOLYSIN® in Combination With Paclitaxel and Carboplatin in Patients With Squamous Cell Carcinoma of the LungNCT00998192 · 2009-10-01 · 1 site observation
COMPLETED
Comparison of NN1250 With Insulin Glargine Plus Insulin Aspart With/Without Metformin and With/Without Pioglitazone in Type 2 DiabetesNCT00972283 · 2009-09-01 · 1 site observation
COMPLETED
Comparison of NN1250 Versus Insulin Glargine in Subjects With Type 2 DiabetesNCT00982644 · 2009-09-01 · 1 site observation
COMPLETED
A Clinical Trial Comparing the Combination of TC Plus Bevacizumab to TC Alone and to TAC for Women With Node-Positive or High-Risk Node-Negative, HER2-Negative Breast CancerNCT00887536 · 2009-05-01 · 1 site observation
COMPLETED
Randomized Phase II Trial of Letrozole With or Without Dasatinib as First and Second-line Treatment for Hormone Receptor-positive, HER2-negative Post-menopausal Breast Cancer That is Unresectable, Locally Recurrent or MetastaticNCT00696072 · 2008-08-01 · 1 site observation
COMPLETED
Sunitinib Plus Prednisone In Patients With Metastatic Castration-Resistant Prostate Cancer After Failure Of Docetaxel ChemotherapyNCT00676650 · 2008-07-01 · 1 site observation
TERMINATED
AMR PH GL 2007 CL001 Phase 3 Trial in Patients With Small Cell Lung Cancer After Failure of First-Line ChemotherapyNCT00547651 · 2007-09-01 · 1 site observation
COMPLETED
Adj TC + Herceptin Early Stage Breast CancerNCT00493649 · 2007-06-01 · 1 site observation
COMPLETED
TAC Versus TC for Adjuvant Breast CancerNCT00493870 · 2007-05-29 · 1 site observation
COMPLETED
ALTTO (Adjuvant Lapatinib And/Or Trastuzumab Treatment Optimisation) Study; BIG 2-06/N063DNCT00490139 · 2007-05-16 · 1 site observation
COMPLETED
Phase II Sunitinib Prog Met AIPCNCT00599313 · 2007-03-01 · 1 site observation
COMPLETED
Efficacy of Alogliptin and Pioglitazone in Subjects With Type 2 Diabetes MellitusNCT00432276 · 2007-01-01 · 1 site observation
COMPLETED
The Ranibizumab for Edema of the mAcula in Diabetes-2 (READ-2) StudyNCT00407381 · 2006-12-01 · 1 site observation
COMPLETED
A Study Of SU011248 Plus Paclitaxel Versus Bevacizumab Plus Paclitaxel In Patients With Advanced Breast CancerNCT00373256 · 2006-11-01 · 1 site observation
COMPLETED
Study of Amrubicin in Patients With Small Cell Lung Cancer Refractory or Progressive to Prior TherapyNCT00375193 · 2006-11-01 · 1 site observation
COMPLETED
Study Comparing Amrubicin Versus Topotecan in Patients With Small Cell Lung Cancer Who Have Responded to Prior Therapy.NCT00319969 · 2006-04-01 · 1 site observation
COMPLETED
Study of Talabostat and Pemetrexed vs. Pemetrexed in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) After Failure of Platinum-Based ChemotherapyNCT00290017 · 2006-02-01 · 1 site observation
TERMINATED
Study of Talabostat + Docetaxel Versus Docetaxel in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) After Failure of Platinum-Based ChemotherapyNCT00243204 · 2006-01-01 · 1 site observation
TERMINATED
DN-101 in Combination With Docetaxel in Androgen-Independent Prostate Cancer (AIPC) (AIPC Study of Calcitriol Enhancing Taxotere [ASCENT-2])NCT00273338 · 2006-01-01 · 1 site observation
TERMINATED
Doxil & Carboplatin Plus HER2+ in Metastatic Breast CancerNCT00303108 · 2005-12-01 · 1 site observation
COMPLETED
Comparison Trial of Letrozole to Anastrozole in the Adjuvant Treatment of Postmenopausal Women With Hormone Receptor and Node Positive Breast CancerNCT00248170 · 2005-12-01 · 1 site observation
COMPLETED
Lapatinib In Combination With Trastuzumab Versus Lapatinib Monotherapy In Subjects With HER2-positive Metastatic Breast CancerNCT00320385 · 2005-11-01 · 1 site observation
COMPLETED
Effect of Ruboxistaurin on Clinically Significant Macular EdemaNCT00133952 · 2005-08-01 · 1 site observation
COMPLETED
Docetaxel or Pemetrexed With or Without Cetuximab in Patients With Recurrent or Progressive Non-Small Cell Lung CancerNCT00095199 · 2005-01-01 · 1 site observation
COMPLETED
GVAX® Vaccine for Prostate Cancer vs Docetaxel & Prednisone in Patients With Metastatic Hormone-Refractory Prostate CancerNCT00089856 · 2004-07-01 · 1 site observation
TERMINATED
Breast Cancer Trial of RPR109881 Versus Capecitabine in Male or Female Patients With Advanced Breast CancerNCT00081796 · 2004-04-01 · 1 site observation
COMPLETED
A Study to Assess Capecitabine (Xeloda®) in Patients With Locally Advanced or Metastatic Breast CancerNCT00077857 · 2003-07-01 · 1 site observation
COMPLETED
Evaluation of Efficacy, Safety and Tolerability of Targretin Capsules in Patients With Advanced or Metastatic Non-small Cell Lung CancerNCT00050960 · 2002-05-01 · 1 site observation
COMPLETED
Randomized Phase III Study Of Exemestane (Aromasin) For 5 Years Versus Tamoxifen for 2.5 to 3 Years Followed By ExemestaneNCT00036270 · 2001-08-01 · 1 site observation
COMPLETED
A Phase III Study of the Efficacy of Taxotere/Aptosyn Versus Taxotere/Placebo in Non-Small Cell Lung Cancer PatientsNCT00085826 · 2001-04-01 · 1 site observation
COMPLETED
Iressa Expanded Access Program (EAP)NCT00034879 · 2000-08-01 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.